| Name | 6-[(9H-Carbazol-4-yloxy)methyl]-4-[2-(2-methoxyphenoxy)ethyl]-3-morpholinone |
|---|---|
| Synonyms |
6-[(9H-Carbazol-4-yloxy)methyl]-4-[2-(2-methoxyphenoxy)ethyl]-3-morpholinone
3-Morpholinone, 6-[(9H-carbazol-4-yloxy)methyl]-4-[2-(2-methoxyphenoxy)ethyl]- VK-II-36 |
| Description | VK-II-36 is a carvedilol analog that suppresses sarcoplasmic reticulum Ca2+release but does not block the β-receptor.VK-II-36 inhibits triggered activities evoked by both early and delayed after depolarizations[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 698.6±55.0 °C at 760 mmHg |
| Molecular Formula | C26H26N2O5 |
| Molecular Weight | 446.50 |
| Flash Point | 376.3±31.5 °C |
| Exact Mass | 446.184174 |
| LogP | 4.25 |
| Vapour Pressure | 0.0±2.2 mmHg at 25°C |
| Index of Refraction | 1.644 |